Vera Therapeutics, Inc.VERANASDAQ

Revenue (LTM)

Net Income (LTM)

$-300M

-96.9% YoY

Free Cash Flow

$-242M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.2B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	1	0	0	-0
Operating Income	-34	-91↓164.2%	-102↓12.2%	-167↓63.9%	-315↓88.7%
Net Income	-33	-89↓173.1%	-96↓7.8%	-152↓58.5%	-300↓96.9%
EBITDA	-32	-89↓174.3%	-92↓3.7%	-144↓56.7%	-292↓101.9%
EPS Diluted	-2.43	-3.35↓37.9%	-2.25↑32.8%	-2.75↓22.2%	-4.66↓69.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	80	43↓45.5%	46↑5.1%	93↑102.8%	355↑282.9%
Total Current Assets	83	126↑52.3%	172↑36.9%	651↑278.6%	729↑11.9%
Total Assets	84	131↑56.9%	176↑33.6%	656↑273.5%	735↑12.1%
Total Current Liabilities	8	26↑232.9%	22↓12.9%	25↑13.8%	53↑110.7%
Total Liabilities	14	55↑285.2%	74↑35.5%	79↑6.3%	130↑65.8%
Total Equity	70	77↑10.5%	102↑32.2%	577↑467.6%	605↑4.7%
Total Debt	5	31↑535.5%	54↑71.7%	55↑1.7%	77↑41.5%
Net Debt	-75	-12↑83.7%	8↑165.9%	-38↓573.5%	-277↓629.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-24	-68↓185.1%	-92↓36.4%	-135↓46.1%	-241↓79.0%
Capital Expenditure	0	-0	-0↓1.6%	-1↓1442.9%	-1↑35.2%
Free Cash Flow	-24	-68↓185.4%	-92↓36.3%	-136↓47.1%	-242↓78.2%
Stock-Based Comp	3	9↑195.1%	11↑29.3%	21↑81.0%	38↑82.3%
Net Change in Cash	26	-36↓239.4%	2↑105.3%	47↑2334.7%	262↑458.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance